Clinuvel Pharmaceuticals Price Chart
*There is no price data available for this ticker
Clinuvel Pharmaceuticals Volume Chart
*There is no volume data available for this ticker
Clinuvel Pharmaceuticals Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
+0.00(+0.00%)
| Open | $7.00 |
|---|---|
| Close | $7.00 |
| Low | $7.00 |
| Low Change | 0.00 (0.00%) |
| High | $7.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $700.00 |
Overnight
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.05(-0.71%)
| Open | $7.00 |
|---|---|
| Close | $6.95 |
| Low | $6.95 |
| Low Change | -0.05 (-0.71%) |
| High | $7.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.05 |
| Volume | 2.912K |
| Dollar Volume | $20.24K |
Premarket Yesterday
*No Trades in Segment
Clinuvel Pharmaceuticals News
There is no current news for this stock at the moment.
Clinuvel Pharmaceuticals Top Trades
Clinuvel Pharmaceuticals's top trade so far today returned +0.00%, while the top short trade returned 0.00%.
Clinuvel Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | — |
|---|---|
| 10 Day Moving Average (SMA10) | — |
| 20 Day Moving Average (SMA20) | — |
| 50 Day Moving Average (SMA50) | — |
| 100 Day Moving Average (SMA100) | — |
| 200 Day Moving Average (SMA200) | — |
Clinuvel Pharmaceuticals Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Clinuvel Pharmaceuticals Stock Splits
There have been no stock splits for Clinuvel Pharmaceuticals (CUVL).
Clinuvel Pharmaceuticals Dividends
There have been no dividends for Clinuvel Pharmaceuticals (CUVL).